CV/COS Webinar: Clip 9

In the world of cancer care, different disease stages present unique challenges and experiences for patients. At Carevive, we recognize the importance of considering the stage of disease when analyzing the impact and quantification of tolerability, physical function, and symptoms. Early-stage disease patients may not be symptomatic, and treatment administration may have minimal interference as they work towards remission or cure. Real-world data collection allows us to gain valuable insights into the varying needs and experiences of patients at different stages, enabling us to tailor care strategies to meet their specific requirements and improve overall outcomes.

Recent Episodes

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

In “Fighting for Coverage,” a patient describes a double war: the physical fight to stay alive and the bureaucratic fight to prove to an insurer that her life is worth the cost. Her account spotlights a core tension in the U.S. system—coverage decisions are increasingly shaped by prior authorizations and desk-based reviewers who…